Qiagen N.V.
NYSE: QGEN0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- New York Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Thierry Bernard
- Employees
- 5,736
- Headquarters
- Venlo, Netherlands
- IPO year
- 1996
- Market cap
- $8.0B
- Website
- https://www.qiagen.com
Loading QGEN…
Loading profile data…Frequently asked questions about QGEN
What does Qiagen N.V. (QGEN) do?
Qiagen N.V. provides sample to insight solutions that transform biological samples into molecular insights worldwide. The company offers sample technology consumables, such as nucleic acid stabilization and purification kits for sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, a...
Where does QGEN trade?
Qiagen N.V. (QGEN) trades on the New York Stock Exchange.
What sector is QGEN in?
Qiagen N.V. (QGEN) operates in the Healthcare sector, specifically in the Medical - Diagnostics & Research industry.
Who is the CEO of Qiagen N.V.?
Thierry Bernard is the chief executive officer of Qiagen N.V. (QGEN).
Where is Qiagen N.V. headquartered?
Qiagen N.V. is headquartered in Netherlands.
Does QGEN pay a dividend?
Yes — Qiagen N.V. (QGEN) paid a trailing twelve-month dividend of USD 0.35 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did QGEN go public?
Qiagen N.V. (QGEN) completed its initial public offering in 1996.